Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial. (2020)
Attributed to:
CANCER: Trials with potential global reach and other challenging trials
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s0140-6736(20)31553-1
PubMed Identifier: 33002429
Publication URI: http://europepmc.org/abstract/MED/33002429
Type: Journal Article/Review
Volume: 396
Parent Publication: Lancet (London, England)
Issue: 10260
ISSN: 0140-6736